ACCORD Trademark

Trademark Overview


On Wednesday, July 31, 2024, a trademark application was filed for ACCORD with the United States Patent and Trademark Office. The USPTO has given the ACCORD trademark a serial number of 98676694. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Friday, May 23, 2025. This trademark is owned by Accord Healthcare, Inc.. The ACCORD trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical services, namely, processing orders for pharmaceutical products and pharmaceutical preparations from retail and central fill pharmacies and healthcare facilities. Distributorship services in the field of generic pharmaceutical products and pharmaceutical preparations; wholesale store services featuring pharmaceutical products and pharmaceutical preparations.

Pharmaceutical drug development services; Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Pharmaceutical research and development; Pharmaceutical research services.
accord

General Information


Serial Number98676694
Word MarkACCORD
Filing DateWednesday, July 31, 2024
Status645 - FINAL REFUSAL - MAILED
Status DateFriday, May 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical services, namely, processing orders for pharmaceutical products and pharmaceutical preparations from retail and central fill pharmacies and healthcare facilities. Distributorship services in the field of generic pharmaceutical products and pharmaceutical preparations; wholesale store services featuring pharmaceutical products and pharmaceutical preparations.
Goods and ServicesPharmaceutical drug development services; Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Pharmaceutical research and development; Pharmaceutical research services.

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, July 31, 2024
Primary Code035
First Use Anywhere DateThursday, May 19, 2005
First Use In Commerce DateThursday, January 1, 2009

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 31, 2024
Primary Code042
First Use Anywhere DateThursday, May 19, 2005
First Use In Commerce DateThursday, January 1, 2009

Trademark Owner History


Party NameAccord Healthcare, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRaleigh, NC 27617

Trademark Events


Event DateEvent Description
Wednesday, July 31, 2024NEW APPLICATION ENTERED
Friday, February 7, 2025ASSIGNED TO EXAMINER
Wednesday, July 31, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 5, 2024TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, August 5, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, February 24, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 24, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 12, 2025NON-FINAL ACTION WRITTEN
Wednesday, February 12, 2025NON-FINAL ACTION E-MAILED
Wednesday, February 12, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 24, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 23, 2025FINAL REFUSAL WRITTEN
Friday, May 23, 2025FINAL REFUSAL E-MAILED
Friday, May 23, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, May 7, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 7, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 7, 2025TEAS/EMAIL CORRESPONDENCE ENTERED